Michael Halstead - Dec 1, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Dec 1, 2022
Transactions value $
-$1,913,014
Form type
4
Date filed
12/2/2022, 06:14 PM
Previous filing
Mar 14, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise $774K +50K $15.47 50K Dec 1, 2022 Direct
transaction ITCI Common Stock Sale -$1.47M -27.2K -54.41% $53.94 22.8K Dec 1, 2022 Direct F1, F2
transaction ITCI Common Stock Sale -$1.22M -22.8K -100% $53.48 0 Dec 1, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Options Exercise $0 -50K -76.73% $0.00 15.2K Dec 1, 2022 Common Stock 50K $15.47 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.68 to $54.6734, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.185 to $53.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 All shares underlying this option have vested.